Oncology Radiopharmaceutical Market Size, Share and Trends Forecast

Report Overview

This report provides a deep insight into the global Oncology Radiopharmaceutical market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Radiopharmaceutical Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Radiopharmaceutical market in any manner.
Global Oncology Radiopharmaceutical Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Chimeric Therapeutics Limited
Fusion Pharma
Lantheus Medical lmaging, Inc.
NanoMab
NuView Life Sciences.
PentixaPharm GmbHPrecirix
RadioMedix
RayzeBio
Telix Pharmaceuticals Limited
Theragnostics Ltd
Vect-Horus

Market Segmentation (by Type)
Oral Drugs
Intravenous Drugs
Other

Market Segmentation (by Application)
Hospitals and Clinics
Pharmaceutical Company
Research Center
Other

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Oncology Radiopharmaceutical Market
• Overview of the regional outlook of the Oncology Radiopharmaceutical Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Radiopharmaceutical Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

FAQ

The Oncology Radiopharmaceutical market research report includes specific segments by region (country), i.e. North America, Europe, Asia Pacific, South America, Middle East and Africa

The Oncology Radiopharmaceutical market report provides global companies with an opportunity to enter new markets, invest in new sectors, analyze consumer reactions, investigate global competition, and ultimately make smart investments.

Oncology Radiopharmaceutical report covers the latest market developments in terms of acquisitions, growth strategies, joint ventures and collaborations, new product launches, and more on industry.

We can provide customization on reports prior to the sale. If you need customization we request you to provide specific details on customization prior to the dispatch. This is because we move fast with your queries as it requires a lot of diligence. There will be additional charges for customization once the report is dispatched to you and will be treated as post-sales query.

Requesting a Sample copy of the report from Xcellent Insights is hassle-free! You can either request it from the report page or call our sales Executive at US: +1 408 627 7717 /UK: +44 208 638 6439 and share/discuss your requirements. Our Team will share the sample copy of the report with you within 12 Working Hours / Shortly.

Ordering a report from Xcellent Insights is hassle-free! You can select a licence type that suits your requirement and proceed to checkout. It will redirect you to the payment gateway with a list of payment options. Be rest assured that we do not store the payment details. Once we receive the payment, a confirmation email will be sent on your registered mail id with details on the report delivery timeline. You can also get your order placed through our business development executives and they will guide you thoroughly.

You should buy this report from Xcellent Insights for a better clarity on market scenarios.
The market report has been prepared using a pragmatic approach to suit your needs.
We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
Besides, customization is a value-added service if you decide to opt.

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncology Radiopharmaceutical
1.2 Key Market Segments
1.2.1 Oncology Radiopharmaceutical Segment by Type
1.2.2 Oncology Radiopharmaceutical Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncology Radiopharmaceutical Market Overview
2.1 Global Market Overview
2.1.1 Global Oncology Radiopharmaceutical Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oncology Radiopharmaceutical Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncology Radiopharmaceutical Market Competitive Landscape
3.1 Global Oncology Radiopharmaceutical Sales by Manufacturers (2019-2024)
3.2 Global Oncology Radiopharmaceutical Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Radiopharmaceutical Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Radiopharmaceutical Sales Sites, Area Served, Product Type
3.6 Oncology Radiopharmaceutical Market Competitive Situation and Trends
3.6.1 Oncology Radiopharmaceutical Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Radiopharmaceutical Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncology Radiopharmaceutical Industry Chain Analysis
4.1 Oncology Radiopharmaceutical Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncology Radiopharmaceutical Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncology Radiopharmaceutical Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Radiopharmaceutical Sales Market Share by Type (2019-2024)
6.3 Global Oncology Radiopharmaceutical Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Radiopharmaceutical Price by Type (2019-2024)
7 Oncology Radiopharmaceutical Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Radiopharmaceutical Market Sales by Application (2019-2024)
7.3 Global Oncology Radiopharmaceutical Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Radiopharmaceutical Sales Growth Rate by Application (2019-2024)
8 Oncology Radiopharmaceutical Market Segmentation by Region
8.1 Global Oncology Radiopharmaceutical Sales by Region
8.1.1 Global Oncology Radiopharmaceutical Sales by Region
8.1.2 Global Oncology Radiopharmaceutical Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Radiopharmaceutical Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Radiopharmaceutical Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Radiopharmaceutical Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Radiopharmaceutical Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Radiopharmaceutical Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis
9.1.1 Novartis Oncology Radiopharmaceutical Basic Information
9.1.2 Novartis Oncology Radiopharmaceutical Product Overview
9.1.3 Novartis Oncology Radiopharmaceutical Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Oncology Radiopharmaceutical SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Chimeric Therapeutics Limited
9.2.1 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Basic Information
9.2.2 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Overview
9.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Market Performance
9.2.4 Chimeric Therapeutics Limited Business Overview
9.2.5 Chimeric Therapeutics Limited Oncology Radiopharmaceutical SWOT Analysis
9.2.6 Chimeric Therapeutics Limited Recent Developments
9.3 Fusion Pharma
9.3.1 Fusion Pharma Oncology Radiopharmaceutical Basic Information
9.3.2 Fusion Pharma Oncology Radiopharmaceutical Product Overview
9.3.3 Fusion Pharma Oncology Radiopharmaceutical Product Market Performance
9.3.4 Fusion Pharma Oncology Radiopharmaceutical SWOT Analysis
9.3.5 Fusion Pharma Business Overview
9.3.6 Fusion Pharma Recent Developments
9.4 Lantheus Medical lmaging, Inc.
9.4.1 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Basic Information
9.4.2 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Overview
9.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Market Performance
9.4.4 Lantheus Medical lmaging, Inc. Business Overview
9.4.5 Lantheus Medical lmaging, Inc. Recent Developments
9.5 NanoMab
9.5.1 NanoMab Oncology Radiopharmaceutical Basic Information
9.5.2 NanoMab Oncology Radiopharmaceutical Product Overview
9.5.3 NanoMab Oncology Radiopharmaceutical Product Market Performance
9.5.4 NanoMab Business Overview
9.5.5 NanoMab Recent Developments
9.6 NuView Life Sciences.
9.6.1 NuView Life Sciences. Oncology Radiopharmaceutical Basic Information
9.6.2 NuView Life Sciences. Oncology Radiopharmaceutical Product Overview
9.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Product Market Performance
9.6.4 NuView Life Sciences. Business Overview
9.6.5 NuView Life Sciences. Recent Developments
9.7 PentixaPharm GmbHPrecirix
9.7.1 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Basic Information
9.7.2 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Overview
9.7.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Market Performance
9.7.4 PentixaPharm GmbHPrecirix Business Overview
9.7.5 PentixaPharm GmbHPrecirix Recent Developments
9.8 RadioMedix
9.8.1 RadioMedix Oncology Radiopharmaceutical Basic Information
9.8.2 RadioMedix Oncology Radiopharmaceutical Product Overview
9.8.3 RadioMedix Oncology Radiopharmaceutical Product Market Performance
9.8.4 RadioMedix Business Overview
9.8.5 RadioMedix Recent Developments
9.9 RayzeBio
9.9.1 RayzeBio Oncology Radiopharmaceutical Basic Information
9.9.2 RayzeBio Oncology Radiopharmaceutical Product Overview
9.9.3 RayzeBio Oncology Radiopharmaceutical Product Market Performance
9.9.4 RayzeBio Business Overview
9.9.5 RayzeBio Recent Developments
9.10 Telix Pharmaceuticals Limited
9.10.1 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Basic Information
9.10.2 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Overview
9.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Market Performance
9.10.4 Telix Pharmaceuticals Limited Business Overview
9.10.5 Telix Pharmaceuticals Limited Recent Developments
9.11 Theragnostics Ltd
9.11.1 Theragnostics Ltd Oncology Radiopharmaceutical Basic Information
9.11.2 Theragnostics Ltd Oncology Radiopharmaceutical Product Overview
9.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Product Market Performance
9.11.4 Theragnostics Ltd Business Overview
9.11.5 Theragnostics Ltd Recent Developments
9.12 Vect-Horus
9.12.1 Vect-Horus Oncology Radiopharmaceutical Basic Information
9.12.2 Vect-Horus Oncology Radiopharmaceutical Product Overview
9.12.3 Vect-Horus Oncology Radiopharmaceutical Product Market Performance
9.12.4 Vect-Horus Business Overview
9.12.5 Vect-Horus Recent Developments
10 Oncology Radiopharmaceutical Market Forecast by Region
10.1 Global Oncology Radiopharmaceutical Market Size Forecast
10.2 Global Oncology Radiopharmaceutical Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology Radiopharmaceutical Market Size Forecast by Country
10.2.3 Asia Pacific Oncology Radiopharmaceutical Market Size Forecast by Region
10.2.4 South America Oncology Radiopharmaceutical Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology Radiopharmaceutical by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Oncology Radiopharmaceutical Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oncology Radiopharmaceutical by Type (2025-2030)
11.1.2 Global Oncology Radiopharmaceutical Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oncology Radiopharmaceutical by Type (2025-2030)
11.2 Global Oncology Radiopharmaceutical Market Forecast by Application (2025-2030)
11.2.1 Global Oncology Radiopharmaceutical Sales (Kilotons) Forecast by Application
11.2.2 Global Oncology Radiopharmaceutical Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncology Radiopharmaceutical Market Size Comparison by Region (M USD)
Table 5. Global Oncology Radiopharmaceutical Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Oncology Radiopharmaceutical Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oncology Radiopharmaceutical Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oncology Radiopharmaceutical Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Radiopharmaceutical as of 2022)
Table 10. Global Market Oncology Radiopharmaceutical Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oncology Radiopharmaceutical Sales Sites and Area Served
Table 12. Manufacturers Oncology Radiopharmaceutical Product Type
Table 13. Global Oncology Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oncology Radiopharmaceutical
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncology Radiopharmaceutical Market Challenges
Table 22. Global Oncology Radiopharmaceutical Sales by Type (Kilotons)
Table 23. Global Oncology Radiopharmaceutical Market Size by Type (M USD)
Table 24. Global Oncology Radiopharmaceutical Sales (Kilotons) by Type (2019-2024)
Table 25. Global Oncology Radiopharmaceutical Sales Market Share by Type (2019-2024)
Table 26. Global Oncology Radiopharmaceutical Market Size (M USD) by Type (2019-2024)
Table 27. Global Oncology Radiopharmaceutical Market Size Share by Type (2019-2024)
Table 28. Global Oncology Radiopharmaceutical Price (USD/Ton) by Type (2019-2024)
Table 29. Global Oncology Radiopharmaceutical Sales (Kilotons) by Application
Table 30. Global Oncology Radiopharmaceutical Market Size by Application
Table 31. Global Oncology Radiopharmaceutical Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Oncology Radiopharmaceutical Sales Market Share by Application (2019-2024)
Table 33. Global Oncology Radiopharmaceutical Sales by Application (2019-2024) & (M USD)
Table 34. Global Oncology Radiopharmaceutical Market Share by Application (2019-2024)
Table 35. Global Oncology Radiopharmaceutical Sales Growth Rate by Application (2019-2024)
Table 36. Global Oncology Radiopharmaceutical Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Oncology Radiopharmaceutical Sales Market Share by Region (2019-2024)
Table 38. North America Oncology Radiopharmaceutical Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Oncology Radiopharmaceutical Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Oncology Radiopharmaceutical Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Oncology Radiopharmaceutical Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Oncology Radiopharmaceutical Sales by Region (2019-2024) & (Kilotons)
Table 43. Novartis Oncology Radiopharmaceutical Basic Information
Table 44. Novartis Oncology Radiopharmaceutical Product Overview
Table 45. Novartis Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis Oncology Radiopharmaceutical SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Basic Information
Table 50. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Overview
Table 51. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Chimeric Therapeutics Limited Business Overview
Table 53. Chimeric Therapeutics Limited Oncology Radiopharmaceutical SWOT Analysis
Table 54. Chimeric Therapeutics Limited Recent Developments
Table 55. Fusion Pharma Oncology Radiopharmaceutical Basic Information
Table 56. Fusion Pharma Oncology Radiopharmaceutical Product Overview
Table 57. Fusion Pharma Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Fusion Pharma Oncology Radiopharmaceutical SWOT Analysis
Table 59. Fusion Pharma Business Overview
Table 60. Fusion Pharma Recent Developments
Table 61. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Basic Information
Table 62. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Overview
Table 63. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Lantheus Medical lmaging, Inc. Business Overview
Table 65. Lantheus Medical lmaging, Inc. Recent Developments
Table 66. NanoMab Oncology Radiopharmaceutical Basic Information
Table 67. NanoMab Oncology Radiopharmaceutical Product Overview
Table 68. NanoMab Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. NanoMab Business Overview
Table 70. NanoMab Recent Developments
Table 71. NuView Life Sciences. Oncology Radiopharmaceutical Basic Information
Table 72. NuView Life Sciences. Oncology Radiopharmaceutical Product Overview
Table 73. NuView Life Sciences. Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. NuView Life Sciences. Business Overview
Table 75. NuView Life Sciences. Recent Developments
Table 76. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Basic Information
Table 77. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Overview
Table 78. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. PentixaPharm GmbHPrecirix Business Overview
Table 80. PentixaPharm GmbHPrecirix Recent Developments
Table 81. RadioMedix Oncology Radiopharmaceutical Basic Information
Table 82. RadioMedix Oncology Radiopharmaceutical Product Overview
Table 83. RadioMedix Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. RadioMedix Business Overview
Table 85. RadioMedix Recent Developments
Table 86. RayzeBio Oncology Radiopharmaceutical Basic Information
Table 87. RayzeBio Oncology Radiopharmaceutical Product Overview
Table 88. RayzeBio Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. RayzeBio Business Overview
Table 90. RayzeBio Recent Developments
Table 91. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Basic Information
Table 92. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Overview
Table 93. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Telix Pharmaceuticals Limited Business Overview
Table 95. Telix Pharmaceuticals Limited Recent Developments
Table 96. Theragnostics Ltd Oncology Radiopharmaceutical Basic Information
Table 97. Theragnostics Ltd Oncology Radiopharmaceutical Product Overview
Table 98. Theragnostics Ltd Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Theragnostics Ltd Business Overview
Table 100. Theragnostics Ltd Recent Developments
Table 101. Vect-Horus Oncology Radiopharmaceutical Basic Information
Table 102. Vect-Horus Oncology Radiopharmaceutical Product Overview
Table 103. Vect-Horus Oncology Radiopharmaceutical Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Vect-Horus Business Overview
Table 105. Vect-Horus Recent Developments
Table 106. Global Oncology Radiopharmaceutical Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Oncology Radiopharmaceutical Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Oncology Radiopharmaceutical Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Oncology Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Oncology Radiopharmaceutical Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Oncology Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Oncology Radiopharmaceutical Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Oncology Radiopharmaceutical Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Oncology Radiopharmaceutical Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Oncology Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Oncology Radiopharmaceutical Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Oncology Radiopharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Oncology Radiopharmaceutical Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Oncology Radiopharmaceutical Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Oncology Radiopharmaceutical Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Oncology Radiopharmaceutical Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Oncology Radiopharmaceutical Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Oncology Radiopharmaceutical
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Radiopharmaceutical Market Size (M USD), 2019-2030
Figure 5. Global Oncology Radiopharmaceutical Market Size (M USD) (2019-2030)
Figure 6. Global Oncology Radiopharmaceutical Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Radiopharmaceutical Market Size by Country (M USD)
Figure 11. Oncology Radiopharmaceutical Sales Share by Manufacturers in 2023
Figure 12. Global Oncology Radiopharmaceutical Revenue Share by Manufacturers in 2023
Figure 13. Oncology Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oncology Radiopharmaceutical Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oncology Radiopharmaceutical Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oncology Radiopharmaceutical Market Share by Type
Figure 18. Sales Market Share of Oncology Radiopharmaceutical by Type (2019-2024)
Figure 19. Sales Market Share of Oncology Radiopharmaceutical by Type in 2023
Figure 20. Market Size Share of Oncology Radiopharmaceutical by Type (2019-2024)
Figure 21. Market Size Market Share of Oncology Radiopharmaceutical by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oncology Radiopharmaceutical Market Share by Application
Figure 24. Global Oncology Radiopharmaceutical Sales Market Share by Application (2019-2024)
Figure 25. Global Oncology Radiopharmaceutical Sales Market Share by Application in 2023
Figure 26. Global Oncology Radiopharmaceutical Market Share by Application (2019-2024)
Figure 27. Global Oncology Radiopharmaceutical Market Share by Application in 2023
Figure 28. Global Oncology Radiopharmaceutical Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oncology Radiopharmaceutical Sales Market Share by Region (2019-2024)
Figure 30. North America Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Oncology Radiopharmaceutical Sales Market Share by Country in 2023
Figure 32. U.S. Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Oncology Radiopharmaceutical Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Oncology Radiopharmaceutical Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Oncology Radiopharmaceutical Sales Market Share by Country in 2023
Figure 37. Germany Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Oncology Radiopharmaceutical Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Oncology Radiopharmaceutical Sales Market Share by Region in 2023
Figure 44. China Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Oncology Radiopharmaceutical Sales and Growth Rate (Kilotons)
Figure 50. South America Oncology Radiopharmaceutical Sales Market Share by Country in 2023
Figure 51. Brazil Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Oncology Radiopharmaceutical Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Oncology Radiopharmaceutical Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Oncology Radiopharmaceutical Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Oncology Radiopharmaceutical Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Oncology Radiopharmaceutical Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Oncology Radiopharmaceutical Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Oncology Radiopharmaceutical Market Share Forecast by Type (2025-2030)
Figure 65. Global Oncology Radiopharmaceutical Sales Forecast by Application (2025-2030)
Figure 66. Global Oncology Radiopharmaceutical Market Share Forecast by Application (2025-2030)

Novartis
Chimeric Therapeutics Limited
Fusion Pharma
Lantheus Medical lmaging, Inc.
NanoMab
NuView Life Sciences.
PentixaPharm GmbHPrecirix
RadioMedix
RayzeBio
Telix Pharmaceuticals Limited
Theragnostics Ltd
Vect-Horus

Speak With Analyst

Name

Corporate Email ID

Country

Phone No.

Your Message

Report Details

Speak With Analyst